Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients
InSightec
InSightec
IRCCS Ospedale San Raffaele
Mayo Clinic
Nationwide Children's Hospital
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Beijing Tiantan Hospital
University Health Network, Toronto
The Children's Hospital of Zhejiang University School of Medicine
M.D. Anderson Cancer Center
University College Cork
Blokhin's Russian Cancer Research Center
M.D. Anderson Cancer Center
Tata Memorial Centre
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
University of Birmingham
Virginia Commonwealth University
Telix Pharmaceuticals (Innovations) Pty Limited
Medical University of Warsaw
Mayo Clinic
Washington University School of Medicine
Tianjin Medical University
Maastricht Radiation Oncology
Leica Microsystems (Schweiz) AG
Istituto Oncologico Veneto IRCCS
West China Hospital
West China Hospital
iOMEDICO AG
Mayo Clinic
Sunnybrook Health Sciences Centre
European Organisation for Research and Treatment of Cancer - EORTC
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Nanfang Hospital, Southern Medical University
Leica Microsystems (Schweiz) AG
OHSU Knight Cancer Institute
St. Jude Children's Research Hospital
Second Affiliated Hospital, School of Medicine, Zhejiang University
Massachusetts General Hospital
Centre Jean Perrin
University of California, San Francisco
Indiana University
LMU Klinikum
RenJi Hospital
Nanjing First Hospital, Nanjing Medical University
Ourotech, Inc.
Huashan Hospital
Royal North Shore Hospital
Universitat Politècnica de València